Update shared on 28 Nov 2025
Fair value Increased 0.63%Analysts have slightly raised their price target for NOCIL from ₹197.25 to ₹198.50, citing minor adjustments in profit margin expectations and future price-to-earnings estimates.
What's in the News
- NOCIL Limited has scheduled a Board Meeting on October 31, 2025, at 14:30 IST to consider and approve the Un-Audited Standalone and Consolidated Financial Results for the quarter and half-year ended September 30, 2025 (Company Filing).
- The agenda also includes reviewing the Limited Review Report, Statement of Assets and Liabilities, and the Cash Flow Statement for the half-year ended September 30, 2025 (Company Filing).
- Other business matters may be discussed during the Board Meeting as determined by participants (Company Filing).
Valuation Changes
- Consensus Analyst Price Target has risen slightly from ₹197.25 to ₹198.50.
- Discount Rate increased marginally from 13.35% to 13.35%.
- Revenue Growth estimate remains virtually unchanged at 11.06%.
- Net Profit Margin has fallen modestly from 10.31% to 9.83%.
- Future P/E ratio estimate moved up from 25.37x to 26.28x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.